Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AMGEN INCAMGN · Entity 2832 | Director | May 19, 2023 | May 23, 2023 |
| Apple Inc.AAPL · Entity 2389 | Director | February 24, 2026 | February 26, 2026 |
| CHEVRON CORPCVX · Entity 2804 | Director | May 25, 2022 | May 27, 2022 |
| SUMISHO AIR LEASE CORPAL · Entity 52868 | Director | May 08, 2019 | May 09, 2019 |
| Uber Technologies, IncUBER · Entity 2867 | Director | May 03, 2026 | May 05, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AMGEN INC
Report date May 19, 2023 · Filed May 23, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 19,682 |
Reported balance
After 2023-05-19 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2023-05-19 · Grant · Acquired 939 · Balance 19,682 F1: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan (the Director Program) and vested immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case, payment will occur according to the elected deferral schedule. F2: These shares include 3,388 Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred RSUs and are paid out in shares of the Company's common stock on a one-to-one basis along with a cash payment for any remaining fractional share amount. |
Filing footnotes · ownership attribution and instrument terms
F1: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan (the Director Program) and vested immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case, payment will occur according to the elected deferral schedule.
F2: These shares include 3,388 Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred RSUs and are paid out in shares of the Company's common stock on a one-to-one basis along with a cash payment for any remaining fractional share amount.
Apple Inc.
Report date February 24, 2026 · Filed February 26, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitSEC Table II · derivative / convertible security · Expires 2027-02-01 | Direct | 1,139 |
Reported balance
After 2026-02-24 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-02-24 · Grant · Acquired 1,139 · Balance 1,139 F1: Automatic grant pursuant to the Apple Inc. Non-Employee Director Stock Plan, as Amended and Restated. F2: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. F3: 100% of these restricted stock units are scheduled to vest on February 1, 2027, assuming continued service through the vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Automatic grant pursuant to the Apple Inc. Non-Employee Director Stock Plan, as Amended and Restated.
F2: Each restricted stock unit represents the right to receive, at settlement, one share of common stock.
F3: 100% of these restricted stock units are scheduled to vest on February 1, 2027, assuming continued service through the vesting date.
CHEVRON CORP
Report date May 25, 2022 · Filed May 27, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 57,483 |
Reported balance
After 2022-05-25 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2022-05-25 · Grant · Acquired 1,303 · Balance 57,483 F1: This number represents stock units issued under the Chevron Corporation Non-Employee Directors' Equity Compensation and Deferral Plan. F2: This number includes the acquisition of dividend equivalent accruals on stock units and the acquisition of stock resulting from the reinvestment of dividends on restricted stock (2,482) issued under the Chevron Corporation Non-Employee Directors' Equity Compensation and Deferral Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: This number represents stock units issued under the Chevron Corporation Non-Employee Directors' Equity Compensation and Deferral Plan.
F2: This number includes the acquisition of dividend equivalent accruals on stock units and the acquisition of stock resulting from the reinvestment of dividends on restricted stock (2,482) issued under the Chevron Corporation Non-Employee Directors' Equity Compensation and Deferral Plan.
SUMISHO AIR LEASE CORP
Report date May 08, 2019 · Filed May 09, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Air Lease Corporation - Class A Common StockSEC Table I · non-derivative | Direct | 30,127 |
Reported balance
After 2019-05-08 transaction · row 1
1 source rowRow 1 · 2019-05-08 · Grant · Acquired 3,390 · Balance 30,127 F1: Restricted stock units (RSUs) granted under the Air Lease Corporation 2014 Equity Incentive Plan, in connection with the reporting person's service as a member of the Board of Directors of the Issuer. Subject to certain conditions, all of these RSUs will vest in full on May 8, 2020, the first anniversary of the grant date. Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock on the vesting date. |
| Air Lease Corporation- Class A Common StockSEC Table I · non-derivative | IndirectSee footnote | 50,000 |
Reported balance
Holding disclosure · report date 2019-05-08 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 50,000 F2: These shares are held by a trust of which the reporting person is a co-trustee. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted stock units (RSUs) granted under the Air Lease Corporation 2014 Equity Incentive Plan, in connection with the reporting person's service as a member of the Board of Directors of the Issuer. Subject to certain conditions, all of these RSUs will vest in full on May 8, 2020, the first anniversary of the grant date. Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock on the vesting date.
F2: These shares are held by a trust of which the reporting person is a co-trustee.
Uber Technologies, Inc
Report date May 03, 2026 · Filed May 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 4,091 |
Reported balance
After 2026-05-03 transaction · row 1
1 source rowRow 1 · 2026-05-03 · Exercise / conversion · Acquired 4,091 · Balance 4,091 F1: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2026-05-03 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-05-03 · Exercise / conversion · Disposed 4,091 · Balance 0 F1: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis. F3: The reporting person was granted 4,091 RSUs on May 6, 2025. The RSUs vested on the date immediately preceding the date of the 2026 annual meeting of the stockholders of the Issuer. Upon vesting, the RSUs became payable in cash or common stock on a one-for-one basis at the election of the Issuer. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 4,045 |
Reported balance
After 2026-05-05 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-05-05 · Grant · Acquired 4,045 · Balance 4,045 F4: The reporting person was granted 4,045 RSUs on May 5, 2026 pursuant to Uber's 2019 Equity Incentive Plan. The RSUs are scheduled to vest on the date immediately preceding the date of the 2027 annual meeting of the stockholders of the Issuer, subject to earlier vesting in certain circumstances. Upon vesting, the RSUs become payable in cash or common stock on a one-for-one basis at the election of the Issuer. |
| Common StockSEC Table I · non-derivative | IndirectTrust | 231,909 |
Reported balance
Holding disclosure · report date 2026-05-03 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 231,909 F2: Shares are held by the Sugar Family Trust for which Mr. Sugar serves as trustee. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis.
F2: Shares are held by the Sugar Family Trust for which Mr. Sugar serves as trustee.
F3: The reporting person was granted 4,091 RSUs on May 6, 2025. The RSUs vested on the date immediately preceding the date of the 2026 annual meeting of the stockholders of the Issuer. Upon vesting, the RSUs became payable in cash or common stock on a one-for-one basis at the election of the Issuer.
F4: The reporting person was granted 4,045 RSUs on May 5, 2026 pursuant to Uber's 2019 Equity Incentive Plan. The RSUs are scheduled to vest on the date immediately preceding the date of the 2027 annual meeting of the stockholders of the Issuer, subject to earlier vesting in certain circumstances. Upon vesting, the RSUs become payable in cash or common stock on a one-for-one basis at the election of the Issuer.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 10, 2021 Filed Feb 11, 2021 00:40 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 1,000 | $71.64 | $71,640.00 |
DisclosureSEC source: 0001127602-21-005058 · form4.xml · nonDerivative · entry 1 SUGAR RONALD D · CIK 0001216519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,805 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2021 Filed Feb 3, 2021 23:38 UTC | Apple Inc. AAPL · Entity 2389 | Exercise / conversionRestricted Stock Unit · Derivative | 3,416 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000320193-21-000025 · wf-form4_161239548384646.xml · derivative · entry 2 SUGAR RONALD D · CIK 0001216519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,416 shares Expires 2021-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date. F1 · price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date. F3 · derivative.exercise_date: This restricted stock unit award was granted on February 26, 2020 and vested entirely on February 1, 2021. All share amounts have been adjusted to reflect the stock split. F3 · derivative.expiration_date: This restricted stock unit award was granted on February 26, 2020 and vested entirely on February 1, 2021. All share amounts have been adjusted to reflect the stock split. Read SEC document |
| February 01, 2021 Filed Feb 3, 2021 23:38 UTC | Apple Inc. AAPL · Entity 2389 | Exercise / conversionCommon Stock | 3,416 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000320193-21-000025 · wf-form4_161239548384646.xml · nonDerivative · entry 1 SUGAR RONALD D · CIK 0001216519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,272 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date. F2 · balance_after: Adjusted to reflect Apple's 4-for-1 stock split (the "stock split"), effective on August 28, 2020. Read SEC document |
| January 13, 2021 Filed Jan 14, 2021 23:25 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionNqso (Right to Buy) · Derivative | 1,000 | $0.00 Strike: $71.64 | $0.00 |
DisclosureSEC source: 0001127602-21-001691 · form4.xml · derivative · entry 3 SUGAR RONALD D · CIK 0001216519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,000 Underlying: Common Stock · 1,000 shares Expires 2022-04-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 13, 2021 Filed Jan 14, 2021 23:25 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 1,000 | $235.99 | $235,990.00 |
DisclosureSEC source: 0001127602-21-001691 · form4.xml · nonDerivative · entry 2 SUGAR RONALD D · CIK 0001216519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,805 F1 · shares: The transaction was made pursuant to a previously adopted plan complying with Rule 10b5-1. F2 · balance_after: These shares include 2,142 Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred RSUs and are paid out in shares of the Company's common stock on a one-to-one basis along with a cash payment for any remaining fractional share amount. Read SEC document |
| January 13, 2021 Filed Jan 14, 2021 23:25 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 1,000 | $71.64 | $71,640.00 |
DisclosureSEC source: 0001127602-21-001691 · form4.xml · nonDerivative · entry 1 SUGAR RONALD D · CIK 0001216519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,805 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 21:57 UTC | Uber Technologies, Inc UBER · Entity 2867 | GrantRestricted Stock Units · Derivative | 4,772 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-21-000214 · primarydocument.xml · derivative · entry 1 SUGAR RONALD D · CIK 0001216519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,772 Underlying: Common Stock · 4,772 shares Expires not disclosed F1 · derivative.exercise_date: The restricted stock units (RSUs) are scheduled to vest on December 31, 2021, subject to earlier vesting in certain circumstances. Upon vesting, RSUs become payable in cash or common stock on a one-for-one basis at the election of the issuer. F1 · derivative.expiration_date: The restricted stock units (RSUs) are scheduled to vest on December 31, 2021, subject to earlier vesting in certain circumstances. Upon vesting, RSUs become payable in cash or common stock on a one-for-one basis at the election of the issuer. Read SEC document |
| August 19, 2020 Filed Aug 19, 2020 22:00 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionNqso (Right to Buy) · Derivative | 1,000 | $0.00 Strike: $54.69 | $0.00 |
DisclosureSEC source: 0001127602-20-023922 · form4.xml · derivative · entry 3 SUGAR RONALD D · CIK 0001216519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 1,000 shares Expires 2021-04-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 19, 2020 Filed Aug 19, 2020 22:00 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 1,000 | $241.02 | $241,020.00 |
DisclosureSEC source: 0001127602-20-023922 · form4.xml · nonDerivative · entry 2 SUGAR RONALD D · CIK 0001216519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,589 F1 · shares: The transaction was made pursuant to a previously adopted plan complying with Rule 10b5-1. F2 · balance_after: These shares include 1,926 Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred RSUs and are paid out in shares of the Company's common stock on a one-to-one basis along with a cash payment for any remaining fractional share amount. Read SEC document |
| August 19, 2020 Filed Aug 19, 2020 22:00 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 1,000 | $54.69 | $54,690.00 |
DisclosureSEC source: 0001127602-20-023922 · form4.xml · nonDerivative · entry 1 SUGAR RONALD D · CIK 0001216519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,589 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 22, 2020 Filed Jul 22, 2020 22:11 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionNqso (Right to Buy) · Derivative | 1,000 | $0.00 Strike: $54.69 | $0.00 |
DisclosureSEC source: 0001127602-20-022000 · form4.xml · derivative · entry 3 SUGAR RONALD D · CIK 0001216519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Underlying: Common Stock · 1,000 shares Expires 2021-04-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 22, 2020 Filed Jul 22, 2020 22:11 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 1,000 | $259.79 | $259,790.00 |
DisclosureSEC source: 0001127602-20-022000 · form4.xml · nonDerivative · entry 2 SUGAR RONALD D · CIK 0001216519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,589 F1 · shares: The transaction was made pursuant to a previously adopted plan complying with Rule 10b5-1. F2 · balance_after: These shares include 1,926 Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred RSUs and are paid out in shares of the Company's common stock on a one-to-one basis along with a cash payment for any remaining fractional share amount. Read SEC document |
| July 22, 2020 Filed Jul 22, 2020 22:11 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 1,000 | $54.69 | $54,690.00 |
DisclosureSEC source: 0001127602-20-022000 · form4.xml · nonDerivative · entry 1 SUGAR RONALD D · CIK 0001216519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,589 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 17, 2020 Filed Jun 17, 2020 22:11 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionNqso (Right to Buy) · Derivative | 1,000 | $0.00 Strike: $54.69 | $0.00 |
DisclosureSEC source: 0001127602-20-019949 · form4.xml · derivative · entry 3 SUGAR RONALD D · CIK 0001216519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,000 Underlying: Common Stock · 1,000 shares Expires 2021-04-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 17, 2020 Filed Jun 17, 2020 22:11 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 1,000 | $228.54 | $228,540.00 |
DisclosureSEC source: 0001127602-20-019949 · form4.xml · nonDerivative · entry 2 SUGAR RONALD D · CIK 0001216519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,576 F1 · shares: The transaction was made pursuant to a previously adopted plan complying with Rule 10b5-1. F2 · balance_after: These shares include 1,913 Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred RSUs and are paid out in shares of the Company's common stock on a one-to-one basis along with a cash payment for any remaining fractional share amount. Read SEC document |
| June 17, 2020 Filed Jun 17, 2020 22:11 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 1,000 | $54.69 | $54,690.00 |
DisclosureSEC source: 0001127602-20-019949 · form4.xml · nonDerivative · entry 1 SUGAR RONALD D · CIK 0001216519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,576 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 27, 2020 Filed May 29, 2020 21:14 UTC | CHEVRON CORP CVX · Entity 2804 | GrantCommon Stock | 2,411 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-018172 · form4.xml · nonDerivative · entry 1 SUGAR RONALD D · CIK 0001216519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,817 F1 · shares: This number represents stock units issued under the Chevron Corporation Non-Employee Directors' Equity Compensation and Deferral Plan. F2 · balance_after: This number includes the acquisition of dividend equivalent accruals on stock units and the acquisition of stock resulting from the reinvestment of dividends on restricted stock (2,002) issued under the Chevron Corporation Non-Employee Directors' Equity Compensation and Deferral Plan. Read SEC document |
| May 20, 2020 Filed May 21, 2020 01:24 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionNqso (Right to Buy) · Derivative | 1,000 | $0.00 Strike: $54.69 | $0.00 |
DisclosureSEC source: 0001127602-20-017431 · form4.xml · derivative · entry 3 SUGAR RONALD D · CIK 0001216519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,000 Underlying: Common Stock · 1,000 shares Expires 2021-04-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 20, 2020 Filed May 21, 2020 01:24 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 1,000 | $229.27 | $229,270.00 |
DisclosureSEC source: 0001127602-20-017431 · form4.xml · nonDerivative · entry 2 SUGAR RONALD D · CIK 0001216519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,482 F1 · shares: The transaction was made pursuant to a previously adopted plan complying with Rule 10b5-1. F2 · balance_after: These shares include 1,819 Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred RSUs and are paid out in shares of the Company's common stock on a one-to-one basis along with a cash payment for any remaining fractional share amount. Read SEC document |
| May 20, 2020 Filed May 21, 2020 01:24 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 1,000 | $54.69 | $54,690.00 |
DisclosureSEC source: 0001127602-20-017431 · form4.xml · nonDerivative · entry 1 SUGAR RONALD D · CIK 0001216519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,482 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 05, 2020 Filed May 8, 2020 00:47 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 846 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-015856 · form4.xml · nonDerivative · entry 1 SUGAR RONALD D · CIK 0001216519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,482 F1 · balance_after: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan (the Director Program) and vested immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case, payment will occur according to the elected deferral schedule. F2 · balance_after: These shares include 1,819 Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred RSUs and are paid out in shares of the Company's common stock on a one-to-one basis along with a cash payment for any remaining fractional share amount. Read SEC document |
| April 22, 2020 Filed Apr 22, 2020 23:07 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionNqso (Right to Buy) · Derivative | 1,000 | $0.00 Strike: $54.69 | $0.00 |
DisclosureSEC source: 0001127602-20-014328 · form4.xml · derivative · entry 3 SUGAR RONALD D · CIK 0001216519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,000 Underlying: Common Stock · 1,000 shares Expires 2021-04-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 22, 2020 Filed Apr 22, 2020 23:07 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 1,000 | $233.35 | $233,350.00 |
DisclosureSEC source: 0001127602-20-014328 · form4.xml · nonDerivative · entry 2 SUGAR RONALD D · CIK 0001216519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,636 F1 · shares: The transaction was made pursuant to a previously adopted plan complying with Rule 10b5-1. F2 · balance_after: These shares include 1,819 Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred RSUs and are paid out in shares of the Company's common stock on a one-to-one basis along with a cash payment for any remaining fractional share amount. Read SEC document |
| April 22, 2020 Filed Apr 22, 2020 23:07 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 1,000 | $54.69 | $54,690.00 |
DisclosureSEC source: 0001127602-20-014328 · form4.xml · nonDerivative · entry 1 SUGAR RONALD D · CIK 0001216519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,636 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 26, 2020 Filed Feb 28, 2020 23:35 UTC | Apple Inc. AAPL · Entity 2389 | GrantRestricted Stock Unit · Derivative | 854 | $0.00 | $0.00 |
DisclosureSEC source: 0000320193-20-000034 · wf-form4_158293293482087.xml · derivative · entry 1 SUGAR RONALD D · CIK 0001216519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 854 Underlying: Common Stock · 854 shares Expires 2021-02-01 F1 · security: Automatic grant pursuant to the Apple Inc. Non-Employee Director Stock Plan. F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. F3 · derivative.exercise_date: 100% of these restricted stock units are scheduled to vest on February 1, 2021, assuming continued service through the vesting date. F3 · derivative.expiration_date: 100% of these restricted stock units are scheduled to vest on February 1, 2021, assuming continued service through the vesting date. Read SEC document |
| February 01, 2020 Filed Feb 4, 2020 23:35 UTC | Apple Inc. AAPL · Entity 2389 | Exercise / conversionRestricted Stock Unit · Derivative | 1,429 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000320193-20-000022 · wf-form4_158085933339951.xml · derivative · entry 2 SUGAR RONALD D · CIK 0001216519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,429 shares Expires 2020-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date. F1 · price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date. F2 · derivative.exercise_date: This restricted stock unit award was granted on March 1, 2019 and vested entirely on February 1, 2020. F2 · derivative.expiration_date: This restricted stock unit award was granted on March 1, 2019 and vested entirely on February 1, 2020. Read SEC document |
| February 01, 2020 Filed Feb 4, 2020 23:35 UTC | Apple Inc. AAPL · Entity 2389 | Exercise / conversionCommon Stock | 1,429 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000320193-20-000022 · wf-form4_158085933339951.xml · nonDerivative · entry 1 SUGAR RONALD D · CIK 0001216519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,714 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date. Read SEC document |
| December 02, 2019 Filed Feb 9, 2021 00:58 UTC | Uber Technologies, Inc UBER · Entity 2867 | GiftCommon Stock | 14,240 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-21-000982 · primarydocument.xml · nonDerivative · entry 1 SUGAR RONALD D · CIK 0001216519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,914 F1 · kind: On December 2, 2019, the reporting person transferred 14,240 shares of Uber common stock to a family trust of which the reporting person is a trustee. The reporting person and members of his immediate family are the sole beneficiaries of the trust. This transaction should have been filed on a Form 5 for the fiscal year ended 2019. Read SEC document |
| November 08, 2019 Filed Nov 14, 2019 01:06 UTC | Uber Technologies, Inc UBER · Entity 2867 | PurchaseCommon Stock | 35,000 | $27.20 | $952,000.00 |
DisclosureSEC source: 0001562180-19-005501 · primarydocument.xml · nonDerivative · entry 1 SUGAR RONALD D · CIK 0001216519 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Family Trust Disclosed balance after: 157,489 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $27.15 to $27.25, inclusive. The reporting person undertakes to provide to Uber Technologies, Inc., any security holder of Uber Technologies, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within this range. F2 · ownership.nature: Shares are held by the Sugar Family Trust for which Mr. Sugar serves as trustee. Read SEC document |
| November 06, 2019 Filed Nov 7, 2019 23:20 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionNqso (Right to Buy) · Derivative | 2,000 | $0.00 Strike: $54.71 | $0.00 |
DisclosureSEC source: 0001127602-19-032229 · form4.xml · derivative · entry 3 SUGAR RONALD D · CIK 0001216519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,000 shares Expires 2020-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 06, 2019 Filed Nov 7, 2019 23:20 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 2,000 | $215.45 | $430,900.00 |
DisclosureSEC source: 0001127602-19-032229 · form4.xml · nonDerivative · entry 2 SUGAR RONALD D · CIK 0001216519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,436 F1 · shares: The transaction was made pursuant to a previously adopted plan complying with Rule 10b5-1. F2 · balance_after: These shares include 1,619 Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred RSUs and are paid out in shares of the Company's common stock on a one-to-one basis along with a cash payment for any remaining fractional share amount. Read SEC document |
| November 06, 2019 Filed Nov 7, 2019 23:20 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 2,000 | $54.71 | $109,420.00 |
DisclosureSEC source: 0001127602-19-032229 · form4.xml · nonDerivative · entry 1 SUGAR RONALD D · CIK 0001216519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,436 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 02, 2019 Filed Oct 3, 2019 21:06 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionNqso (Right to Buy) · Derivative | 2,000 | $0.00 Strike: $54.71 | $0.00 |
DisclosureSEC source: 0001127602-19-030032 · form4.xml · derivative · entry 3 SUGAR RONALD D · CIK 0001216519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 Underlying: Common Stock · 2,000 shares Expires 2020-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 02, 2019 Filed Oct 3, 2019 21:06 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 2,000 | $193.58 | $387,160.00 |
DisclosureSEC source: 0001127602-19-030032 · form4.xml · nonDerivative · entry 2 SUGAR RONALD D · CIK 0001216519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,436 F1 · shares: The transaction was made pursuant to a previously adopted plan complying with Rule 10b5-1. F2 · balance_after: These shares include 1,619 Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred RSUs and are paid out in shares of the Company's common stock on a one-to-one basis along with a cash payment for any remaining fractional share amount. Read SEC document |
| October 02, 2019 Filed Oct 3, 2019 21:06 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 2,000 | $54.71 | $109,420.00 |
DisclosureSEC source: 0001127602-19-030032 · form4.xml · nonDerivative · entry 1 SUGAR RONALD D · CIK 0001216519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,436 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 04, 2019 Filed Sep 4, 2019 22:08 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionNqso (Right to Buy) · Derivative | 2,000 | $0.00 Strike: $54.71 | $0.00 |
DisclosureSEC source: 0001127602-19-027931 · form4.xml · derivative · entry 3 SUGAR RONALD D · CIK 0001216519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,000 Underlying: Common Stock · 2,000 shares Expires 2020-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 04, 2019 Filed Sep 4, 2019 22:08 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 2,000 | $206.70 | $413,400.00 |
DisclosureSEC source: 0001127602-19-027931 · form4.xml · nonDerivative · entry 2 SUGAR RONALD D · CIK 0001216519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,336 F1 · shares: The transaction was made pursuant to a previously adopted plan complying with Rule 10b5-1. F2 · balance_after: These shares include 1,519 Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred RSUs and are paid out in shares of the Company's common stock on a one-to-one basis along with a cash payment for any remaining fractional share amount. Read SEC document |
| September 04, 2019 Filed Sep 4, 2019 22:08 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 2,000 | $54.71 | $109,420.00 |
DisclosureSEC source: 0001127602-19-027931 · form4.xml · nonDerivative · entry 1 SUGAR RONALD D · CIK 0001216519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,336 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 07, 2019 Filed Aug 8, 2019 23:09 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionNqso (Right to Buy) · Derivative | 2,000 | $0.00 Strike: $54.71 | $0.00 |
DisclosureSEC source: 0001127602-19-026276 · form4.xml · derivative · entry 3 SUGAR RONALD D · CIK 0001216519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Underlying: Common Stock · 2,000 shares Expires 2020-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 07, 2019 Filed Aug 8, 2019 23:09 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 2,000 | $183.04 | $366,080.00 |
DisclosureSEC source: 0001127602-19-026276 · form4.xml · nonDerivative · entry 2 SUGAR RONALD D · CIK 0001216519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,336 F1 · shares: The transaction was made pursuant to a previously adopted plan complying with Rule 10b5-1. F2 · balance_after: These shares include 1,519 Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred RSUs and are paid out in shares of the Company's common stock on a one-to-one basis along with a cash payment for any remaining fractional share amount. Read SEC document |
| August 07, 2019 Filed Aug 8, 2019 23:09 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 2,000 | $54.71 | $109,420.00 |
DisclosureSEC source: 0001127602-19-026276 · form4.xml · nonDerivative · entry 1 SUGAR RONALD D · CIK 0001216519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,336 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 03, 2019 Filed Jul 8, 2019 20:23 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionNqso (Right to Buy) · Derivative | 2,000 | $0.00 Strike: $54.71 | $0.00 |
DisclosureSEC source: 0001127602-19-024112 · form4.xml · derivative · entry 3 SUGAR RONALD D · CIK 0001216519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,000 Underlying: Common Stock · 2,000 shares Expires 2020-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 03, 2019 Filed Jul 8, 2019 20:23 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 2,000 | $187.58 | $375,160.00 |
DisclosureSEC source: 0001127602-19-024112 · form4.xml · nonDerivative · entry 2 SUGAR RONALD D · CIK 0001216519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,336 F1 · shares: The transaction was made pursuant to a previously adopted plan complying with Rule 10b5-1. F2 · balance_after: These shares include 1,519 Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred RSUs and are paid out in shares of the Company's common stock on a one-to-one basis along with a cash payment for any remaining fractional share amount. Read SEC document |
| July 03, 2019 Filed Jul 8, 2019 20:23 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 2,000 | $54.71 | $109,420.00 |
DisclosureSEC source: 0001127602-19-024112 · form4.xml · nonDerivative · entry 1 SUGAR RONALD D · CIK 0001216519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,336 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 05, 2019 Filed Jun 5, 2019 22:55 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionNqso (Right to Buy) · Derivative | 2,000 | $0.00 Strike: $54.71 | $0.00 |
DisclosureSEC source: 0001127602-19-020940 · form4.xml · derivative · entry 3 SUGAR RONALD D · CIK 0001216519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 2,000 shares Expires 2020-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 05, 2019 Filed Jun 5, 2019 22:55 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 2,000 | $175.68 | $351,360.00 |
DisclosureSEC source: 0001127602-19-020940 · form4.xml · nonDerivative · entry 2 SUGAR RONALD D · CIK 0001216519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,219 F1 · shares: The transaction was made pursuant to a previously adopted plan complying with Rule 10b5-1. F2 · balance_after: These shares include 1,402 Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred RSUs and are paid out in shares of the Company's common stock on a one-to-one basis along with a cash payment for any remaining fractional share amount. Read SEC document |
| June 05, 2019 Filed Jun 5, 2019 22:55 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 2,000 | $54.71 | $109,420.00 |
DisclosureSEC source: 0001127602-19-020940 · form4.xml · nonDerivative · entry 1 SUGAR RONALD D · CIK 0001216519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,219 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 29, 2019 Filed May 31, 2019 21:33 UTC | CHEVRON CORP CVX · Entity 2804 | GrantCommon Stock | 1,901 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-020347 · form4.xml · nonDerivative · entry 1 SUGAR RONALD D · CIK 0001216519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,404 F1 · shares: This number represents stock units issued under the Chevron Corporation Non-Employee Directors' Equity Compensation and Deferral Plan. F2 · balance_after: This number includes the acquisition of dividend equivalent accruals on stock units and the acquisition of stock resulting from the reinvestment of dividends on restricted stock (1,560) issued under the Chevron Corporation Non-Employee Directors' Equity Compensation and Deferral Plan. Read SEC document |
| May 09, 2019 Filed May 13, 2019 22:08 UTC | Uber Technologies, Inc UBER · Entity 2867 | GrantCommon Stock | 45,567 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-19-013315 · doc4.xml · nonDerivative · entry 1 SUGAR RONALD D · CIK 0001216519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,154 F1 · shares: Consists of restricted stock units ("RSUs") for which the performance condition was satisfied upon the effectiveness of the Company's initial public offering. Certain of the RSUs remain subject to service-based vesting conditions. Read SEC document |
| May 08, 2019 Filed May 9, 2019 21:52 UTC | SUMISHO AIR LEASE CORP AL · Entity 52868 | GrantAir Lease Corporation - Class A Common Stock | 3,390 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-005790 · edgar.xml · nonDerivative · entry 1 SUGAR RONALD D · CIK 0001216519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,127 F1 · shares: Restricted stock units (RSUs) granted under the Air Lease Corporation 2014 Equity Incentive Plan, in connection with the reporting person's service as a member of the Board of Directors of the Issuer. Subject to certain conditions, all of these RSUs will vest in full on May 8, 2020, the first anniversary of the grant date. Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock on the vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.